Point72 Hong Kong LTD Applied Therapeutics Inc. Transaction History

Point72 Hong Kong LTD

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.76 - $2.64 $418 - $1,452	-550 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$8.77 - $18.29 $482 - $1,005	-55 Reduced 9.09%	550 $5,000
Q3 2021 Nov 15, 2021	BUY	$13.54 - $22.06 $8,191 - $13,346	605 New	605 $10,000
Q2 2021 Aug 16, 2021	SELL	$14.05 - $25.04 $5,957 - $10,616	-424 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$16.57 - $28.65 $115 - $200	-7 Reduced 1.62%	424 $8,000
Q4 2020 Feb 16, 2021	BUY	$15.44 - $24.23 $3,998 - $6,275	259 Added 150.58%	431 $9,000
Q3 2020 Nov 16, 2020	SELL	$19.43 - $35.36 $23,102 - $42,043	-1,189 Reduced 87.36%	172 $4,000
Q2 2020 Aug 14, 2020	BUY	$29.41 - $51.23 $31,027 - $54,047	1,055 Added 344.77%	1,361 $49,000
Q1 2020 May 15, 2020	BUY	$19.54 - $55.47 $5,979 - $16,973	306 New	306 $10,000

140

112M

1.68M

1.91M

Ticker APLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,020,700
Market Cap $42.3M
Description
Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.